SREBF2 and hepatocellular carcinoma: To further investigate if SREBP2 directly regulates VLDL secretion in hepatocytes, we used CRISPR/Cas9 to knock out SREBF2 in human hepatoma Huh7 cells and mouse hepatocyte AML12 cells with or without LDLR (Figure S2A–D, Supporting Information).